Pallas Capital Advisors LLC Sana Biotechnology, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.43 Billion
- Q2 2025
A detailed history of Pallas Capital Advisors LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 39,564 shares of SANA stock, worth $160,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,564
Previous 17,559
125.32%
Holding current value
$160,234
Previous $30,000
260.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SANA
# of Institutions
170Shares Held
115MCall Options Held
337KPut Options Held
337K-
Flagship Pioneering Inc. Cambridge, MA25MShares$101 Million17.82% of portfolio
-
Black Rock Inc. New York, NY11MShares$44.7 Million0.0% of portfolio
-
Baillie Gifford & CO10.2MShares$41.3 Million0.02% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$41.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.87MShares$31.9 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $770M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...